Continuing a long tradition of honoring excellence in the public health field, APHA today announced the winners of its 2015 national awards. And the accolades are well-deserved.
FDA won cheers from the public health community today in announcing its final determination that partially hydrogenated oil is no longer recognized as safe.
Two court rulings drew cheers this week from APHA and public health advocates. One blocks one of the most extreme abortion bans in the U.S. and the other requires tobacco companies to admit they designed products to be as addictive as possible.
For the first time in six years, Congress has passed a joint budget resolution. While that may seem like progress on a deeply divided Capitol Hill, the measure signifies a nearly wholesale retreat for public health.
The U.S. House of Representatives yesterday approved a framework to guide federal spending for the next fiscal year with dangerous implications for public health.
Public health experts discussed an array of issues critical to making the U.S. the healthiest nation Monday during a kick-off forum for National Public Health Week.
Michael Botticelli, the new director of national drug control policy, discussed our nation's drug use epidemic in a meeting with APHA members.
While we've seen improvements under the Affordable Care Act, health disparities persist. Health leaders and policymakers took up the conversation during The Atlantic Health Forum yesterday in Washington, D.C.
Mary Wakefield, administrator of the Health Resources and Services Administration, has been named acting deputy secretary of the U.S. Department of Health and Human Services. She becomes second in command at the agency.
A preventable epidemic. That’s how public health and safety leaders, including APHA, diagnosed the deadly toll of motor vehicle crashes during a news conference today while releasing the 2015 Roadmap of State Highway Safety Laws.
While the least productive Congress in modern history drew to a close last week, our nation’s elected and appointed leaders still managed to advance key public health priorities in 2014.
The fate of stalled U.S. surgeon general nominee Vivek Murthy rests with the Senate this week.